Annual Net Margin
-146.30%
+26.46%+15.32%
31 December 2023
Summary:
Sangamo Therapeutics annual net profit margin is currently -146.30%, with the most recent change of +26.46% (+15.32%) on 31 December 2023. During the last 3 years, it has fallen by -43.93% (-42.91%). SGMO annual net margin is now -200.23% below its all-time high of -48.73%, reached on 31 December 1996.SGMO Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
21.60%
+10.17 K%+100.21%
30 September 2024
Summary:
Sangamo Therapeutics quarterly net profit margin is currently 21.60%, with the most recent change of +10.17 thousand% (+100.21%) on 30 September 2024. Over the past year, it has increased by +1129.95% (+101.95%). SGMO quarterly net margin is now at all-time high.SGMO Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.3% | +102.0% |
| 3 y3 years | -42.9% | +112.9% |
| 5 y5 years | -80.8% | +117.4% |
SGMO Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -42.9% | +15.3% | at high | +100.2% |
| 5 y | 5 years | -80.8% | +15.3% | at high | +100.2% |
| alltime | all time | -200.2% | +86.1% | at high | +100.2% |
Sangamo Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 21.60%(-100.2%) |
| June 2024 | - | -10.15 K%(-0.6%) |
| Mar 2024 | - | -10.21 K%(+245.6%) |
| Dec 2023 | -146.30%(-15.3%) | -2952.74%(+166.4%) |
| Sept 2023 | - | -1108.35%(-33.8%) |
| June 2023 | - | -1675.29%(<-9900.0%) |
| Mar 2023 | - | 13.38%(-107.0%) |
| Dec 2022 | -172.76%(+7.3%) | -190.87%(-5.0%) |
| Sept 2022 | - | -200.89%(+36.7%) |
| June 2022 | - | -146.96%(-5.7%) |
| Mar 2022 | - | -155.78%(+16.3%) |
| Dec 2021 | -161.05%(+57.3%) | -133.98%(-19.8%) |
| Sept 2021 | - | -166.96%(-1.3%) |
| June 2021 | - | -169.23%(-3.2%) |
| Mar 2021 | - | -174.78%(+11.1%) |
| Dec 2020 | -102.37%(+10.2%) | -157.38%(+5772.4%) |
| Sept 2020 | - | -2.68%(-98.4%) |
| June 2020 | - | -166.70%(-49.2%) |
| Mar 2020 | - | -328.18%(-4054.0%) |
| Dec 2019 | -92.93%(+14.9%) | 8.30%(-106.7%) |
| Sept 2019 | - | -124.36%(-27.9%) |
| June 2019 | - | -172.58%(-67.0%) |
| Mar 2019 | - | -522.24%(+650.9%) |
| Dec 2018 | -80.91%(-45.8%) | -69.55%(+27.6%) |
| Sept 2018 | - | -54.51%(-29.8%) |
| June 2018 | - | -77.70%(-51.4%) |
| Mar 2018 | - | -159.75%(+59.6%) |
| Dec 2017 | -149.23%(-59.6%) | -100.11%(-4.3%) |
| Sept 2017 | - | -104.59%(-30.9%) |
| June 2017 | - | -151.35%(-68.8%) |
| Mar 2017 | - | -485.61%(+350.2%) |
| Dec 2016 | -369.58%(+259.0%) | -107.87%(-83.9%) |
| Sept 2016 | - | -671.80%(-6.4%) |
| June 2016 | - | -717.86%(+71.6%) |
| Mar 2016 | - | -418.42%(+172.4%) |
| Dec 2015 | -102.94%(+78.7%) | -153.63%(+42.4%) |
| Sept 2015 | - | -107.89%(-25.6%) |
| June 2015 | - | -145.08%(+267.9%) |
| Mar 2015 | - | -39.43%(+36.5%) |
| Dec 2014 | -57.59%(-47.8%) | -28.89%(-52.5%) |
| Sept 2014 | - | -60.76%(-9.6%) |
| June 2014 | - | -67.22%(-28.0%) |
| Mar 2014 | - | -93.30%(-21.3%) |
| Dec 2013 | -110.32%(+7.3%) | -118.56%(+10.1%) |
| Sept 2013 | - | -107.67%(+37.0%) |
| June 2013 | - | -78.60%(-47.2%) |
| Mar 2013 | - | -148.93%(+282.5%) |
| Dec 2012 | -102.81%(-70.3%) | -38.94%(-67.0%) |
| Sept 2012 | - | -117.99%(-5.8%) |
| June 2012 | - | -125.23%(-44.1%) |
| Mar 2012 | - | -224.18%(+67.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | -346.45%(+190.0%) | -133.93%(-74.0%) |
| Sept 2011 | - | -514.49%(-24.1%) |
| June 2011 | - | -677.61%(+55.6%) |
| Mar 2011 | - | -435.36%(+145.3%) |
| Dec 2010 | -119.46%(+42.6%) | -177.46%(-39.9%) |
| Sept 2010 | - | -295.45%(+399.4%) |
| June 2010 | - | -59.16%(-1.1%) |
| Mar 2010 | - | -59.84%(+156.1%) |
| Dec 2009 | -83.77%(-44.2%) | -23.37%(-80.4%) |
| Sept 2009 | - | -119.39%(+25.1%) |
| June 2009 | - | -95.45%(-55.9%) |
| Mar 2009 | - | -216.41%(+474.6%) |
| Dec 2008 | -150.14%(-36.4%) | -37.66%(-77.8%) |
| Sept 2008 | - | -169.29%(-35.2%) |
| June 2008 | - | -261.05%(-9.5%) |
| Mar 2008 | - | -288.32%(+19.6%) |
| Dec 2007 | -236.10%(+4.2%) | -241.13%(+31.4%) |
| Sept 2007 | - | -183.57%(-8.4%) |
| June 2007 | - | -200.50%(-46.8%) |
| Mar 2007 | - | -376.86%(-7.6%) |
| Dec 2006 | -226.56%(-57.7%) | -408.03%(+155.1%) |
| Sept 2006 | - | -159.92%(-14.6%) |
| June 2006 | - | -187.23%(+45.7%) |
| Mar 2006 | - | -128.46%(-33.4%) |
| Dec 2005 | -535.14%(-49.1%) | -192.77%(-78.3%) |
| Sept 2005 | - | -890.05%(+10.1%) |
| June 2005 | - | -808.61%(-41.7%) |
| Mar 2005 | - | -1387.89%(-8.8%) |
| Dec 2004 | -1050.80%(+159.8%) | -1521.50%(-42.7%) |
| Sept 2004 | - | -2657.56%(+7.5%) |
| June 2004 | - | -2471.21%(+581.2%) |
| Mar 2004 | - | -362.76%(+116.6%) |
| Dec 2003 | -404.54%(-41.0%) | -167.50%(-67.1%) |
| Sept 2003 | - | -509.66%(-19.4%) |
| June 2003 | - | -632.05%(+20.3%) |
| Mar 2003 | - | -525.41%(+1733.9%) |
| Dec 2002 | -685.33%(+32.6%) | -28.65%(-98.6%) |
| Sept 2002 | - | -2069.17%(+108.6%) |
| June 2002 | - | -992.08%(+10.8%) |
| Mar 2002 | - | -895.61%(+475.8%) |
| Dec 2001 | -516.87%(+95.7%) | -155.55%(-93.4%) |
| Sept 2001 | - | -2355.48%(+1215.3%) |
| June 2001 | - | -179.08%(-44.9%) |
| Mar 2001 | - | -325.24%(+22.4%) |
| Dec 2000 | -264.08%(+52.9%) | -265.63%(+20.2%) |
| Sept 2000 | - | -220.90%(-4.3%) |
| June 2000 | - | -230.92%(-31.4%) |
| Mar 2000 | - | -336.80% |
| Dec 1999 | -172.73%(+7.2%) | - |
| Dec 1998 | -161.19%(+32.6%) | - |
| Dec 1997 | -121.53%(+149.4%) | - |
| Dec 1996 | -48.73% | - |
FAQ
- What is Sangamo Therapeutics annual net profit margin?
- What is the all time high annual net margin for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual net margin year-on-year change?
- What is Sangamo Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly net margin year-on-year change?
What is Sangamo Therapeutics annual net profit margin?
The current annual net margin of SGMO is -146.30%
What is the all time high annual net margin for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual net profit margin is -48.73%
What is Sangamo Therapeutics annual net margin year-on-year change?
Over the past year, SGMO annual net profit margin has changed by +26.46% (+15.32%)
What is Sangamo Therapeutics quarterly net profit margin?
The current quarterly net margin of SGMO is 21.60%
What is the all time high quarterly net margin for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly net profit margin is 21.60%
What is Sangamo Therapeutics quarterly net margin year-on-year change?
Over the past year, SGMO quarterly net profit margin has changed by +1129.95% (+101.95%)